Why Hims & Hers Stock Rebounded on Wednesday
Hims & Hers (NYSE: HIMS) stock was a heartening comeback story on Wednesday, following something of a rout earlier in the ...
Eli Lilly shares climb for seven consecutive sessions
Eli Lilly (NYSE:LLY) shares rose for seven straight sessions, as the stock ended 1.5% higher at $915.2 on Wednesday. The U.S. pharmaceutical giant gained over 5% in the preceding six sessions. The ...
Hims & Hers: Brace For Impact As It Faces A Possible 18% Revenue Hit
Hims & Hers stock drops 26% as FDA resolves semaglutide shortage, threatening GLP-1 revenue. Click here to find out why HIMS ...
Why Hims & Hers Health, Inc. (HIMS) Went Down on Tuesday
We recently published an article titled Two of 10 Worst-Performing Stocks Fall to All-Time Lows on Tuesday. In this article, ...
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money ...
Hosted on MSN10h
Wall Street's Most Wanted: 2 Highly Shorted Stocks Right Now
Short-selling is an interesting part of the stock market that can be dangerous and even controversial. Investors selling ...
Hims & Hers price target raised to $44 from $28 at TD Cowen
TD Cowen raised the firm’s price target on Hims & Hers to $44 from $28 and keeps a Buy rating on the shares. The firm continues to believe ...
Hims & Hers price target raised to $39 from $24 at Truist
Truist analyst Jailendra Singh raised the firm’s price target on Hims & Hers to $39 from $24 and keeps a Hold rating on the shares after ...
UK stock investors are piling into this under-the-radar share up 270%! Should I join them?
This writer noticed that UK stock investors have been buying an obscure share that fell 26% yesterday but is still up nearly ...